
Mathilde Merlet
Mathilde Merlet is the general manager for Canada at Eli Lilly & Co., a pharmaceutical company that has seen significant market success with its GLP-1 products, positioning itself strongly against competitors like Novo Nordisk.
Power1,854
Reach41,445
Country presence
Recent news mentions
Mathilde Merlet, president and general manager of Lilly Canada Inc., applauded the committee’s positive recommendation.
Second Alzheimer’s-treating drug should be publicly covered, Canada’s Drug Agency recommendsThe Globe and Mail·
Canada· 2026-09-17
Mathilde Merlet, Eli Lilly’s general manager for Canada, discussed the unprecedented efficacy of the new class of medication.
Canada will be a launching pad for the global race for generic OzempicThe Globe and Mail·
Canada· 2026-01-30










